These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31195170)

  • 1. Design, synthesis and biological evaluation of 3,4-diaryl-1,2,5-oxadiazole-2/5-oxides as highly potent inhibitors of tubulin polymerization.
    Hong Y; Zhao Y; Yang L; Gao M; Li L; Man S; Wang Z; Guan Q; Bao K; Zuo D; Wu Y; Zhang W
    Eur J Med Chem; 2019 Sep; 178():287-296. PubMed ID: 31195170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combretastatin linked 1,3,4-oxadiazole conjugates as a Potent Tubulin Polymerization inhibitors.
    Kamal A; Srikanth PS; Vishnuvardhan MV; Kumar GB; Suresh Babu K; Hussaini SM; Kapure JS; Alarifi A
    Bioorg Chem; 2016 Apr; 65():126-36. PubMed ID: 26943479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale Design, Synthesis, Cytotoxicity Evaluation, and Molecular Docking Studies of 1,3,4-oxadiazole Analogues.
    Ahsan MJ; Choupra A; Sharma RK; Jadav SS; Padmaja P; Hassan MZ; Al-Tamimi ABS; Geesi MH; Bakht MA
    Anticancer Agents Med Chem; 2018; 18(1):121-138. PubMed ID: 28425854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of newer 1,3,4-oxadiazole and 1,2,4-triazole based Topsentin analogues as anti-proliferative agent targeting tubulin.
    Naaz F; Ahmad F; Lone BA; Pokharel YR; Fuloria NK; Fuloria S; Ravichandran M; Pattabhiraman L; Shafi S; Shahar Yar M
    Bioorg Chem; 2020 Jan; 95():103519. PubMed ID: 31884140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyrazole-oxadiazole conjugates: synthesis, antiproliferative activity and inhibition of tubulin polymerization.
    Kamal A; Shaik AB; Polepalli S; Reddy VS; Kumar GB; Gupta S; Krishna KV; Nagabhushana A; Mishra RK; Jain N
    Org Biomol Chem; 2014 Oct; 12(40):7993-8007. PubMed ID: 25181296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, biological evaluation and cocrystal structures with tubulin of chiral β-lactam bridged combretastatin A-4 analogues as potent antitumor agents.
    Zhou P; Liang Y; Zhang H; Jiang H; Feng K; Xu P; Wang J; Wang X; Ding K; Luo C; Liu M; Wang Y
    Eur J Med Chem; 2018 Jan; 144():817-842. PubMed ID: 29306206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and biological evaluation of novel combretastatin A-4 thio derivatives as microtubule targeting agents.
    Stefański T; Mikstacka R; Kurczab R; Dutkiewicz Z; Kucińska M; Murias M; Zielińska-Przyjemska M; Cichocki M; Teubert A; Kaczmarek M; Hogendorf A; Sobiak S
    Eur J Med Chem; 2018 Jan; 144():797-816. PubMed ID: 29291446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indolyl-α-keto-1,3,4-oxadiazoles: Synthesis, anti-cell proliferation activity, and inhibition of tubulin polymerization.
    Tantak MP; Malik M; Klingler L; Olson Z; Kumar A; Sadana R; Kumar D
    Bioorg Med Chem Lett; 2021 Apr; 37():127842. PubMed ID: 33556575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,3,4-oxadiazole-2-thione Derivatives; Novel Approach for Anticancer and Tubulin Polymerization Inhibitory Activities.
    Abdel-Aziz M; Metwally KA; Gamal-Eldeen AM; Aly OM
    Anticancer Agents Med Chem; 2015; 16(2):269-77. PubMed ID: 26343141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, biological evaluation and molecular modeling of 1,3,4-oxadiazoline analogs of combretastatin-A4 as novel antitubulin agents.
    Hu Y; Lu X; Chen K; Yan R; Li QS; Zhu HL
    Bioorg Med Chem; 2012 Jan; 20(2):903-9. PubMed ID: 22192936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of 4-morpholino-6-(1,2,3,6-tetrahydropyridin-4-yl)-N-(3,4,5-trimethoxyphenyl)-1,3,5-triazin-2-amine analogues as tubulin polymerization inhibitors.
    Narva S; Chitti S; Amaroju S; Bhattacharjee D; Rao BB; Jain N; Alvala M; Sekhar KVGC
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3794-3801. PubMed ID: 28684120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 2-step synthesis of Combretastatin A-4 and derivatives as potent tubulin assembly inhibitors.
    Barnes NG; Parker AW; Ahmed Mal Ullah AA; Ragazzon PA; Hadfield JA
    Bioorg Med Chem; 2020 Oct; 28(19):115684. PubMed ID: 32912434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of highly potent tubulin polymerization inhibitors: Design, synthesis, and structure-activity relationships of novel 2,7-diaryl-[1,2,4]triazolo[1,5-a]pyrimidines.
    Huo XS; Jian XE; Ou-Yang J; Chen L; Yang F; Lv DX; You WW; Rao JJ; Zhao PL
    Eur J Med Chem; 2021 Aug; 220():113449. PubMed ID: 33895499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel hybrid nocodazole analogues as tubulin polymerization inhibitors and their antiproliferative activity.
    Kale SS; Jedhe GS; Meshram SN; Santra MK; Hamel E; Sanjayan GJ
    Bioorg Med Chem Lett; 2015 May; 25(9):1982-5. PubMed ID: 25817588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of cis-restricted triazole/tetrazole mimics of combretastatin-benzothiazole hybrids as tubulin polymerization inhibitors and apoptosis inducers.
    Subba Rao AV; Swapna K; Shaik SP; Lakshma Nayak V; Srinivasa Reddy T; Sunkari S; Shaik TB; Bagul C; Kamal A
    Bioorg Med Chem; 2017 Feb; 25(3):977-999. PubMed ID: 28034647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and bioevaluation of diarylpyrazoles as antiproliferative agents.
    Wang C; Yang S; Du J; Ni J; Wu Y; Wang J; Guan Q; Zuo D; Bao K; Wu Y; Zhang W
    Eur J Med Chem; 2019 Jun; 171():1-10. PubMed ID: 30901597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and antitumor evaluation of novel chiral diaryl substituted azetidin-2-one derivatives as tubulin polymerization inhibitors.
    Liang Y; Zhang M; Zhou P; Liu M; Li J; Wang Y
    Bioorg Chem; 2021 Oct; 115():105239. PubMed ID: 34399321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and biological evaluation of 1-substituted -2-aryl imidazoles targeting tubulin polymerization as potential anticancer agents.
    Li L; Quan D; Chen J; Ding J; Zhao J; Lv L; Chen J
    Eur J Med Chem; 2019 Dec; 184():111732. PubMed ID: 31610372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3,5-Diaryl-1H-pyrazolo[3,4-b]pyridines as potent tubulin polymerization inhibitors: Rational design, synthesis and biological evaluation.
    Zhai M; Liu S; Gao M; Wang L; Sun J; Du J; Guan Q; Bao K; Zuo D; Wu Y; Zhang W
    Eur J Med Chem; 2019 Apr; 168():426-435. PubMed ID: 30831410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of new 2-chloro-4-aminopyrimidine and 2,6-dimethyl-4-aminopyrimidine derivatives as tubulin polymerization inhibitors.
    Xu S; An B; Li Y; Luo X; Li X; Jia X
    Bioorg Med Chem Lett; 2018 Jun; 28(10):1769-1775. PubMed ID: 29673981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.